Protocol R2810-ONC-1806. Observational study of CemiplimAb Survivorship Epidemiology for patients with Cutaneous Squamous Cell Carcinoma.
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.
Contact us today to request an appointment.Virtual & Telemedicine available.
Learn more news and information related to COVID-19.